VRBPAC Agrees with WHO Recommends Two Strain Change for 2015-16 Flu Vaccine
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) finalized their decision today on the 2015-16 influenza vaccine strains and officially voted to go with the recommended WHO changes, recommending the two strain change.
FFF Enterprises wins 10 MarCom Awards in several categories
FFF Enterprises is proud to announce our latest achievement in winning three platinum, five gold and two honorable mention awards in the 2014 MarCom Awards competition.
Flublok® Influenza Vaccine Now Approved for Adults Ages 18 and Older
Protein Sciences Corporation announced today that the U.S. FDA has approved Flublok influenza vaccine for all adults aged 18 years and older.
Nation’s Largest Distributor of Influenza Vaccines Prepared to Respond to Vaccine Delays
Despite multiple manufacturers experiencing delays, FFF has large quantities immediately available
Important News! Flu Vaccine Delivery Update
FFF Enterprises Shipping Status of Influenza Vaccine Products.
Study Finds Fluzone High-Dose More Effective in Older Adults Than Standard Vaccine
Sanofi Pasteur announced on Wednesday that the New England Journal of Medicine published results that showed Fluzone High-Dose was more effective in preventing influenza in adults aged 65 years and older than Fluzone. The large-scale, multi-center efficacy trial found that Fluzone High-Dose was approximately 24 percent more effective than the standard vaccine.
Why Aren't Pregnant Women Getting the Flu Vaccine?
Both mother and fetus are at increased risk for complications of flu infection during pregnancy. And prenatal care providers say they're advising women to get the flu vaccine, in line with recommendations from various organizations. But many pregnant women don't understand the importance of this advice -- and don't get the vaccine.
USE THIS ONE - FFF Enterprises Announces 2013-2014 MyFluVaccine Ordering Is Now Underway
Customers are encouraged to order early to receive select manufacturer discounts and rebates, and to secure their preferred delivery dates.
Is the Flu Vaccine Right for You?
Many people think they do not need a flu vaccine.
Protect Yourself and Others with an Annual Flu Shot
Why getting vaccinated benefits you and your community.
The New High-Dose Flu Vaccine: An Extra Boost for U.S. Seniors
New research comparing the new Fluzone High-Dose vaccine and the seasonal flu vaccine sheds light on how ineffective the latter vaccine has been for the elderly.
New Intradermal Flu Vaccine Now Available!
FFF is pleased to offer Fluzone Intradermal, a new influenza vaccine presentation from sanofi pasteur that uses an easy-to-use microinjection system designed to consistently deposit vaccine antigens into the dermal layer of the skin of adults.
Winner in the BioSupply Trends
Quarterly Drawing for a Nook Color
Congratulations to Tommy Hill at Methodist Healthcare Central in Memphis! Tommy placed his order for flu vaccine with MyFluVaccine.com as the result of the July BioSupply Trends Quarterly promotion, and he was automatically entered in our drawing for a Nook Color. Happy reading to Tommy who is the lucky winner!
FFF Enterprises Makes FluMist® by MedImmune a Key Addition to Its Flu Vaccine Portfolio – February 7, 2011
FFF Enterprises Supports National Influenza Vaccination Week – December 6, 2010
Special Offer on Fluvirin Multi-Dose Vials
Free Syringes with Purchase!
Effective October 13th, FFF is pleased to extend a special offer of free syringes with all new orders of Fluvirin Multi-Dose Vials. An equivalent number of syringes to administer the product will be shipped free-of-charge with your Fluvirin Multi-Dose order when you let us know that you want the complimentary syringes—InviroSNAP! Safety Syringes with 25 gauge x 1 inch needles.
To place your Fluvirin order and receive this special offer, please call your FFF representative or Wow! Customer Care at (800) 843-7477.
FDA Licenses New Intradermal Flu Vaccine
The U.S. Food and Drug Administration has approved Sanofi Pasteur’s supplemental biologics license application for licensure of Fluzone Intradermal (Influenza Virus Vaccine). The vaccine is the first influenza vaccine licensed in the U.S. that uses a microinjection system for intradermal delivery. The vaccine’s prefilled microinjection system features an ultra-fine needle that is 90 percent shorter than the typical needle used for intramuscular injection, and it is designed to consistently deposit vaccine antigens into the dermal layer of the skin. The dermal layer contains a high concentration of specialized cells known as dendritic cells, which play a key role in generating an immune response. It contains 9 mcg of hemagglutinin per strain of influenza in a .1 mL dose (versus 15 mcg of hemagglutinin per strain of influenza in a .5 mL dose in the intramuscular Fluzone vaccine), yet in clinical trials the intradermal vaccine produced an immune response at rates similar to the intramuscular vaccine. Fluzone Intradermal is indicated for active immunization of adults 18 through 64 years old against influenza caused by the virus subtypes A and type B contained in the vaccine.
Giving Your Flu Clinic a Shot at Success
A behind-the-scenes look at what goes into a successful flu immunization clinic, whether it’s large or small.
A Brief History of The Flu Vaccine
Flu season is still about a month away, but the U.S. Centers for Disease Control (CDC) wants Americans to get vaccinated now. There's no cure for the influenza virus, which in its worldwide perambulations can mutate from a simple runny nose-and-sore-throat to a fatal illness. Read full article.
Flu Shots Lower Risk of Blood Clots
People who get their annual flu shot may reap an extra benefit: a reduction in their risk of developing a blood clot.
Is the Flu Vaccine a Good Idea for Your Family
The flu season is from November to April, with most cases occurring between late December and early March, but the vaccine is usually offered between September and mid-November.
Health Care Personnel Initiative to Improve Influenza Vaccination Toolkit
Influenza is a contagious respiratory illness that can be easily spread through person to person contact. Influenza can cause mild to severe illness and in some cases may lead to death. Annually, between 5 percent and 20 percent of the population become ill with influenza, and on average more than 200,000 persons are hospitalized and 36,000 people die.